I
nfection is a common complication in patients admitted to the intensive care unit (ICU). It is estimated that 37% to 51.2% of all ICU patients are treated for infection during ICU stay (1) (2) (3) . Acute renal failure (ARF) is a common complication as well in ICU patients: Up to two thirds of patients will develop ARF (4) and on average 5% to 10% of ICU patients will be treated with renal replacement therapy (RRT) for severe ARF (5) (6) (7) . Although the underlying cause in the development of ARF is often multifactorial, it is well known that infection plays a crucial role (2, 5, 6, 8 -10) , but also vice versa, ARF may contribute to acquiring infection (11) (12) (13) . However, limited data are available on the epidemiology of infection in this specific cohort of ICU patients. In a previous report, we demonstrated that ICU patients with ARF requiring RRT were more susceptible to bloodstream infection than those not requiring RRT (12) . In addition, Thakar et al (11) demonstrated that, in cardiac surgery patients, the occurrence rate of infection and sepsis is greater in patients with ARF who are treated with RRT compared with patients with ARF who are not treated with RRT.
The aim of this study was to evaluate the cause of infection in a well-defined cohort of general ICU patients with ARF treated with RRT and to test the hypothesis whether infection resulted in worse outcome.
MATERIALS AND METHODS

Study Design, Patients, and Clinical Setting.
A 5-year retrospective observational cohort study was conducted on patients admitted between January 1, 2000, and December 31, 2004 , in the 54-bed general ICU of the Ghent University Hospital. The unit is managed as a closed unit; a team of qualified ICU physicians is present in the unit 24 hours per day and 7 days per week. All patients who had ARF and were treated with RRT were included in the study. Exclusion criteria were as follows: extracorporeal blood purification techniques for other reasons than ARF, patients on chronic RRT, RRT initiated before admission to the ICU, and RRT immediately after kidney transplantation. Treatment episodes with peritoneal dialysis, a modality incidentally used in patients with cirrhosis or decompensated heart failure, were also not considered.
In case a patient needed multiple RRT episodes during the same hospitalization or was admitted multiple times to the ICU, only the first RRT-episode was considered. Indications for RRT, as well as the modality chosen (i.e., intermittent/continuous hemodialysis, continuous venovenous hemofiltration or hemodiafiltration, or slow extended daily dialysis), were determined in consensus between the attending intensivists and nephrologists. Typically, most patients were treated by more than one modality during an episode of ARF. Continuous venovenous hemofiltration or hemodiafiltration was used as a modality in hemodynamically unstable patients and continuous hemodialysis was preferred in patients with severe lactic acidosis. Slow extended daily dialysis was an emerging modality used in severely ill patients. The other patients were treated with intermittent hemodialysis.
Routine microbiological surveillance of all patients was performed by thrice weekly culturing of oral swabs and urine samples as well as thrice weekly culturing of tracheal aspirates in those who were mechanically ventilated. Anal swabs were taken once weekly. When clinically indicated, additional cultures were taken from other body sites (e.g., catheters and surgical wounds). Blood cultures were sampled on a routine basis every time a patients' body temperature exceeded 38.4°C or when infection was suspected on other clinical grounds such as hemodynamic instability, respiratory insufficiency, or unexplained altered mental status. Blood samples were processed using BacT/Alert (Organon Teknika, Durnham, NC). Antimicrobial treatment was determined by the attending intensivist in communication with the infectious disease specialist and microbiologist, and discussed once weekly during a multidisciplinary staff meeting.
Data Collection and Definitions. The demographic, biochemical, laboratory, and microbiological data were collected. Additionally, severity of illness at ICU admission was assessed by Acute Physiology and Chronic Health Evaluation (APACHE) II score in all patients except pediatric patients and patients after cardiac surgery, because the APACHE II score has not been validated in these cohorts. Need for organ support (vasoactive therapy and mechanical ventilation), antimicrobial therapy within the same hospitalization period, type of infection, number of infections, and moment of start of therapy for infection (before initiation of RRT, during RRT, or after discontinuation of RRT) were also recorded. All data were collected from the electronic pharmacy, ICU, and hospital registries.
The presence of infection was established according to a stepwise algorithm. A patient was considered for inclusion in case of antimicrobial treatment for at least 3 days. In a second step, two investigators (ER, EAJH) reviewed the patient's charts for evidence and type of infection. Patients were included when they had two of the systemic inflammatory response criteria (fever and leucocytosis and/or increased C-reactive protein) (14, 15) and organ-specific signs of infection according to the criteria established by the Centers for Disease Control (16) . Patients who died within 3 days after starting antimicro- a Calculated for 477 patients. Because the APACHE II scoring system was not validated in cardiac surgery ICU and pediatric ICU patients, these categories are not evaluated by this scoring system in our units. In addition, there were 72 patient files with missing data for calculation of the APACHE II score. RRT, renal replacement therapy. a Chi-square test for the difference of distribution of the episode of infection between infections starting before initiation of RRT, during RRT, or after discontinuation of RRT, p Ͻ 0.001. bial therapy and in whom infection was confirmed in the patient file were also included in the study. Patients who received prophylactic antimicrobial therapy were not included.
Vasoactive therapy was defined as the need for any dose of epinephrine, norepinephrine, vasopressin, dobutamine, and milrinone, or the administration of dopamine in a dose of 4 g⅐kg Ϫ1 ⅐min Ϫ1 or higher. Respiratory failure was defined as the need for invasive mechanical ventilation. Antimicrobial resistance was defined as in vitro resistance to ceftazidime for Gramnegative bacteria, because in our hospital this was considered to be an indicator of epidemic extended-spectrum beta-lactamase-producing strains or hyperproducers of beta-lactamases, and, therefore, was a sign of infection with organisms that are resistant to multiple drugs (17) . Because susceptibility patterns for Pseudomonas aeruginosa vary, these isolates were considered resistant when there was resistance to at least one of the following antipseudomonal antibiotics: ceftazidime, imipenem, ciprofloxacin, or piperacillin (17) . Staphylococci were defined as resistant when there was resistance for methicillin, and other Gram-positive bacteria in the case of ampicillin resistance. Candida spp. were defined resistant when there was resistance against fluconazole, and anaerobe bacteria when there was resistance against metronidazole.
Statistical Analyses. Parametric and nonparametric variables are presented as numbers (%) and median (interquartile range). For comparative tests on continuous and discrete variables, the Mann-Whitney U, Pearson chisquare, Friedman, and Wilcoxon tests were used when appropriate. Survival curves were prepared using the Kaplan-Meier method, and survival distributions were compared using the log-rank test. The association of infection with hospital mortality was assessed in an unadjusted analysis and with a multivariable logistic-regression model. Variables selected for inclusion in the regression model were those with a p value Յ0.25 in the bivariate analysis when comparing survivors and nonsurvivors or those with a clinically plausible association with hospital mortality. Potential colinearity was tested by means of a correlation matrix. To assess linearity of continuous variables, a smoothing scatter plot with the locally weighted scatterplot smoothing statistic was used. Interaction between the different covari- 
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Urinary tract infection Other site of infection Unknown Figure 1 . Types of infection distributed according to the number of infectious episode. Data are presented as n (%) or median (interquartile range).
ates was also tested. Statistical significance was accepted for a two-sided p value of Ͻ0.05, and analyses were performed using software packages SPSS 12.0.0 (SPSS, Chicago, IL) and MedCalc 9.2.0.1 (MedCalc Software, Mariakerke, Belgium). The study was approved by the Ethics Committee of the Ghent University Hospital and performed in accordance with the Declaration of Helsinki.
RESULTS
During the 5-year study period, 15,443 patients were admitted to the ICU. Of these, 731 patients (4.7%) were treated with RRT. After exclusions (n ϭ 84), 647 patients were retained for further analysis. Clinical characteristics of the patients are summarized in Table 1 .
Epidemiology of Infection in Patients With ARF Treated With RRT. A total of 519 patients (80.2%) had an episode of infection. Of these, 193 patients (37.2%) had two or more episodes of infection, 66 patients (12.7%) had three or more episodes of infection, and ten patients (1.9%) had four episodes of infection. Details are presented in Table 2 . The first episode of infection started before initiation of RRT in 301 patients (58.0%), during RRT in 192 patients (37.0%), and after discontinuation of RRT in 26 patients (5.0%). Median time from the start of infection to RRT was 1 day (interquartile range 1-4) for all patients with infection and 3 days (1-7) for patients with infection before initiation of RRT.
Respiratory tract infection was observed most frequently (54.3%), followed by intra-abdominal (11.8%), urinary tract (9.5%), and bloodstream infection (7.7%). The distribution of the types of infection according to the episode of infection is illustrated in Figure 1 . Respiratory tract infection was more often observed during the first episode, whereas bloodstream and urinary tract infections were more often observed during subsequent episodes (p ϭ 0.001).
Infections were caused by Gram-negative organisms in 34.4%, Gram-positive organisms in 21.6% and yeasts in 11.7%, while no pathogen could be identified in 32.4% (Table 2) . Regarding the microbiological etiology, no differences were observed. The first infection was caused by an antimicrobial-resistant microorganism in 66 patients (20.4% of microbiologically documented infections). In total, 96 patients (18.0%) with a microbiologically documented infection suffered from infection caused by an antimicrobial-resistant microorganism. Mortality was comparable in patients with antimicrobial-susceptible and -resistant microorganisms (first infection 63.8% vs. 65.2%, p ϭ 0.836; all infections 64.1% vs. 63.6%, p ϭ 0.931).
Compared with patients without infection, patients whose course was compli- cated with infection needed significantly more vasoactive therapy and mechanical ventilation and had a significant longer duration of RRT, vasoactive therapy, and mechanical ventilation. Patients with infection had significantly longer ICU and hospital length of stay, and significantly higher hospital mortality (Table 3) . However, survival analysis (Kaplan-Meier method) could not demonstrate a difference in hospital mortality (log-rank test, p ϭ 0.071; Fig. 2 ). Outcome in Patients With ARF Treated With RRT. Characteristics of hospital survivors and nonsurvivors are listed in Table 4 . Nonsurvivors were older and were more severely ill as illustrated by the higher APACHE II score; they had a greater proportion of patients with infection and of patients treated with vasoactive therapy and mechanical ventilation. In addition, the time to infection was longer in nonsurvivors compared with survivors. Not surprisingly, survivors had a longer length of stay in the ICU and hospital.
After adjustment for different covariates in two different models, one model including APACHE II score and another not including APACHE II score, infection was not independently associated with hospital mortality (Table 5) .
DISCUSSION
Infection heralds an increasing problem among patients admitted to the ICU, not only because of its high morbidity and mortality, but also because of the considerable socioeconomic implications associated with this condition (18) . Although there are data on risk factors and outcome of patients with ARF treated with RRT, there are only limited data on the epidemiology of infection in this cohort (11, 12, 19 -21) .
In this study, 80% of ICU patients who had ARF treated with RRT were treated for infection during their ICU stay, and one third had more than one infectious episode. In the period before RRT was initiated, the occurrence rate of infections was 46%. This is comparable with that reported by others in general ICU populations (35%-51.2%) (1-3) . During RRT, an additional 40% infection episode was registered. The median time between initiation of RRT and start of infection before RRT was only 3 days (interquartile range, 1-7). Therefore, Ն50% of patients with infection before initiation of RRT were on antimicrobial therapy during RRT. At the moment of their infection, many of these patients already may have had severe ARF, not yet treated with RRT. On the other hand, infection may have been the cause of ARF in another considerable number of patients. These data, therefore, underline the complicated interaction between ARF and infection.
In an unadjusted analysis, it was found that patients with infection were more severely ill and had higher mortality compared with patients without infection. However, after correction for covariates, infection was no longer associated with increased odds for mortality. Therefore, it may be likely that these covariates, which can be summarized as severity of illness, act as potential confounders in this model for mortality in patients with ARF treated with RRT.
The distribution of different types of infection did not differ from that observed in other large studies concerning the epidemiology of infection in ICUs (1, 2) . The predominant nosocomial infection was pneumonia, followed by intraabdominal and bloodstream infection. Nevertheless, from the moment RRT was initiated, the relative number of nosocomial bloodstream infections increased. Infections were mainly caused by Gramnegative bacteria, followed by Grampositive bacteria and yeasts. Among Gram-negative and Gram-positive bacteria, about a fifth and a quarter were identified to be resistant against multiple antibiotic agents. Antimicrobial resistance was not associated with increased inhospital mortality. This was in line with a previous study by our group in patients with ARF and bloodstream infection, in which antimicrobial resistance did not affect hospital mortality as well (19) . In 30.5% of patients we could not identify a causative microorganism. This proportion is comparable with other studies on the epidemiology of infection in ICU patients (2, 3) .
Patients with chronic kidney disease, both dialysis dependent and independent, are at increased risk for sepsis (22) (23) (24) . Several pathophysiological factors have been proposed that enhance the risk for infection in patients with chronic kidney disease (25) . There are less data in medical literature on this in patients with ARF. However, many of the factors that may contribute to the development of infection in patients with chronic kidney disease are also present in patients with ARF. Patients with ARF on RRT necessitate the insertion of an extra intravascular catheter, and are, therefore, at risk for bloodstream infection (25) . Several uremic retention compounds such as leptin (26) , advanced glycation end products (27) , and guanidines (28) interfere with normal white blood cell function, phagocytosis, or endothelial function, and thus impact negatively on immunity. Acidosis may also impair immune function by depressant effects on polymorphonuclear and lymphocyte function (25, 29 -31) . Acidosis also has important inflammatory effects leading to hypotension and lung and intestinal injury, thereby facilitating systemic breakthrough of microorganisms (32) (33) (34) (35) (36) (37) . Several factors will interfere with normal respiratory function and increase the risk for pulmonary infection. Volume overload and inflammation may lead to interstitial edema, pulmonary vascular congestion, pleural effusions, intraabdominal hypertension, and decreased gas exchange (35, 38 -40) . Also, loss of muscle mass, caused by immobilization and oversedation, due to retention of sedative drugs, may prolong the duration of mechanical ventilation and hence the time at risk for infection or other lifethreatening complications. Finally, malnutrition occurs in almost half of patients with ARF and leads to impaired immunologic function and infection (41) (42) (43) .
Because this was a retrospective study, a clinical definition of infection was used, which may have lead to an overestimation of the true occurrence rate of infection among the cohort studied. Nonetheless, to prevent systematic confounding of our data, some precautions were taken. First, to rule out that preemptive or preventive antimicrobial therapy was scored as infection, all patient files were screened to search for evidence of infection, and patients who had received antimicrobials for 2 days or less were not retained in our database. Second, in our unit, antimicrobial therapy is supervised by a multidisciplinary team of intensivists, infectious disease specialists, and microbiologists. This strict approach guarantees that only clinically relevant infections are treated. Finally, the distribution of the types of infections and the microbial etiology observed in this study were similar to those in other reports. On the other hand, our data sample is large, and as far as we are aware this is the first study detailing the epidemiology of infection in such a well-defined and specific cohort of critically ill patients. Both latter characteristics may be considered as important strengths of this study.
CONCLUSION
We found a high occurrence rate of infection in this large and specific cohort of critically ill patients with ARF who were treated with RRT. One third of patients developed more than one episode of infection. The predominant infection was pneumonia, followed by intra-abdominal and bloodstream infection. In an unadjusted analysis, it was found that patients with infection were more severely ill and had an increased length of stay (a surrogate marker of hospital resource use) and worse outcome than those without infection. However, infection was not an independent risk factor for hospital mortality.
